Every patient is unique.
Their treatment should be too.

Creating the new standard of care for interventional pulmonary embolism treatment

Data driven

An integrated real-time feedback mechanism gives physicians the ability to track clot resolution and generates a powerful new source of data to fuel future innovations.

 

User-centered design

Designed by a leading interventional radiologist and cardiologist, our steerable, all-in-one angiography, infusion, and monitoring catheter is designed to streamline procedures, improve lytic delivery, and reduce inventory needs.

Personalized, precision medicine

For the first time, providers can monitor clot resolution and know precisely when to stop the medication, reducing complications and improving outcomes.

Why We’re Innovating

 

900,000 Americans experience a pulmonary embolism annually

 

Pulmonary embolism (PE) is a major public health problem, causing 100,000 deaths and costing $10 billion in the US every year. 280,000 PEs can be treated with catheter directed thrombolysis (CDT) annually.

 

PE causes difficulty breathing, heart failure, & death

 

When a PE occurs, a blood clot obstructs the blood flow in the lungs, causing pressure to build on the heart, which makes it difficult for patients to breathe. The goal of CDT is to dissolve the clot and normalize the pressure.

 

Imprecise treatment leads to costly complications

 

Too much lytic may case bleeding complications, but not enough can cause long term pulmonary hypertension. An inability to find just the right time to stop the medication leads to 10.9% 30 day readmission rates and 22.3% 180 day readmission rate for CDT.

Meet the Flow Medical Team

Industry leaders with a passion for improving patient care and advancing medicine through innovative technology solutions.

  • Jonathan Paul, MD

    CO-FOUNDER

    CHIEF SCIENTIFIC OFFICER

    Dr. Paul is an Interventional Cardiologist and Associate Professor of Medicine at the University of Chicago Medical Center.

    Twitter | LinkedIn | Clinical Profile

  • Osman Ahmed, MD

    CO-FOUNDER

    CHIEF MEDICAL OFFICER

    Dr. Ahmed is an Interventional Radiologist and Associate Professor of Radiology at the University of Chicago Medical Center.

    Twitter | LinkedIn | Clinical Profile

  • Jennifer Fried

    CO-FOUNDER

    CEO

    Jennifer is a healthcare entrepreneur and investor. Most recently, she was the co-founder/CEO of Explorer Surgical, which sold to GHX in 2021.

    Twitter | LinkedIn

Let’s talk about how we can work together to improve care.